Hongbin Sun - MicroPort Scientific Chief Officer
| MCRPF Stock | USD 0.81 0.03 3.85% |
Executive
Mr. Hongbin Sun is Chief Financial Officer of MicroPort Scientific Corporationration Mr. Sun has served as a Director and the company chief financial officer since July 22, 2010. He was also a supervisor of MP Shanghai until July 2010. Mr. Sun has over 10 years of finance experience. Mr. Sun was the director and general manager of Otsuka China from 2006 to July 2010. From 2004 to 2006, he served as a financial director of Otsuka China. From 1998 to 2003, Mr. Sun was an assistant manager of the Shanghai office of KPMG. Mr. Sun is a member of Chinese Institute of Certified Public Accountants and is also a Chartered Financial Analyst since 2012.
| Age | 48 |
| Tenure | 12 years |
| Phone | 86 21 3895 4600 |
| Web | https://www.microport.com |
MicroPort Scientific Management Efficiency
The company has return on total asset (ROA) of (0.0705) % which means that it has lost $0.0705 on every $100 spent on assets. This is way below average. Similarly, it shows a return on equity (ROE) of (0.25) %, meaning that it generated substantial loss on money invested by shareholders. MicroPort Scientific's management efficiency ratios could be used to measure how well MicroPort Scientific manages its routine affairs as well as how well it operates its assets and liabilities.Similar Executives
| Showing other executives | EXECUTIVE Age | ||
| Michele Allegretto | Glaukos Corp | N/A | |
| Reay MD | Sight Sciences | N/A | |
| John Shumaker | Paragon 28 | N/A | |
| James Chase | Anika Therapeutics | N/A | |
| Suzanne Armstrong | Orthofix Medical | N/A | |
| Tom Huang | Sight Sciences | N/A | |
| Stephen Deitsch | Paragon 28 | 52 | |
| Robert Thomson | Artivion | 54 | |
| Mark Karshner | Orthopediatrics Corp | N/A | |
| Daniel Esq | CONMED | 60 | |
| Matt Brinckman | Paragon 28 | N/A | |
| Matthew Millard | Paragon 28 | N/A | |
| MD FACS | Glaukos Corp | N/A | |
| Lisa Funiciello | Anika Therapeutics | N/A | |
| Kimberly Lockwood | CONMED | N/A | |
| John Ferrell | CONMED | 56 | |
| Frank Vizesi | Orthofix Medical | N/A | |
| Robert JD | Paragon 28 | 57 | |
| Lee Burnes | Avanos Medical | N/A | |
| Trui Hebbelinck | LivaNova PLC | 52 | |
| Richard Glaze | CONMED | 58 | |
Management Performance
| Return On Equity | -0.25 | |||
| Return On Asset | -0.0705 |
MicroPort Scientific Leadership Team
Elected by the shareholders, the MicroPort Scientific's board of directors comprises two types of representatives: MicroPort Scientific inside directors who are chosen from within the company, and outside directors, selected externally and held independent of MicroPort. The board's role is to monitor MicroPort Scientific's management team and ensure that shareholders' interests are well served. MicroPort Scientific's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, MicroPort Scientific's outside directors are responsible for providing unbiased perspectives on the board's policies.
| Qiyi Luo, Chief Officer | ||
| Jonathan Chen, Sr. VP of International Operation and Investor Relations | ||
| Kongrong Pan, VP Shanghai | ||
| Zhaohua Chang, Founder, Chairman, CEO and Member of Remuneration Committee | ||
| FCS FCIS, Company Sec | ||
| Yan Zhang, Pres Shanghai | ||
| Junder Chiang, Chief HR Officer | ||
| Hongbin Sun, Chief Officer | ||
| Glendy Wang, Chief Officer |
MicroPort Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right pink sheet is not an easy task. Is MicroPort Scientific a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
| Return On Equity | -0.25 | |||
| Return On Asset | -0.0705 | |||
| Profit Margin | (0.48) % | |||
| Operating Margin | (0.53) % | |||
| Current Valuation | 4.92 B | |||
| Shares Outstanding | 1.82 B | |||
| Shares Owned By Insiders | 49.14 % | |||
| Shares Owned By Institutions | 17.84 % | |||
| Price To Earning | 217.50 X | |||
| Price To Book | 3.51 X |
Currently Active Assets on Macroaxis
Other Information on Investing in MicroPort Pink Sheet
MicroPort Scientific financial ratios help investors to determine whether MicroPort Pink Sheet is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in MicroPort with respect to the benefits of owning MicroPort Scientific security.